Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Mark Onaitis

Thoracic Surgery (Cardiothoracic Vascular Surgery) San Diego, CA Medical Doctor

NPI 1841310638 CMS profile 729528

200 W Arbor Dr, San Diego, CA 92103

Open in the dashboard

General payments

$207,207

225 records reported · program years 2019–2025

Research payments

$18,429

Paid to them · 5 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Mark Onaitis of San Diego, CA is reported in the CMS Open Payments database as having received $207,207 across 225 general payments and $18,429 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $9,171 17
2024 General $44,672 21
2023 General $51,732 19
2022 General $55,132 57
2021 General $10,263 43
2021 Research $17,625 1
2020 General $22,170 32
2020 Research $804 4
2019 General $14,067 36

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Mark Onaitis
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Mark Onaitis were reported at $9,171. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Mark Onaitis Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $14,067 $886 $178–$3,167 $163
2020 $22,170 $341 $108–$1,605 $114
2021 $10,263 $453 $125–$1,886 $132
2022 $55,132 $695 $180–$2,566 $149
2023 $51,732 $745 $205–$2,662 $160
2024 $44,672 $799 $214–$2,967 $164
2025 $9,171 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Intuitive Surgical, Inc. $121,315 65 payments
  2. Medtronic, Inc. $44,944 101 payments
  3. Covidien LP $29,718 36 payments
  4. Serpex Medical Inc $8,798 4 payments
  5. AstraZeneca Pharmaceuticals LP $1,350 4 payments
  6. Galvanize Therapeutics, Inc $330 3 payments
  7. Davol Inc. $262 5 payments
  8. Atricure, Inc. $189 1 payment
  9. Boston Scientific Corporation $122 1 payment
  10. E.R. Squibb & Sons, L.L.C. $60 1 payment
  11. Other $120 4 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $141,915 26 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $40,550 19 payments
  3. Travel and Lodging $12,667 52 payments
  4. Food and Beverage $7,575 126 payments
  5. Education $4,500 2 payments
Products named General payments · program years 2019–2025
  1. Da Vinci Surgical System $121,315 65 payments
  2. LigaSure Vessel Sealing $13,949 26 payments
  3. Sonicision $5,500 2 payments
  4. Signia $4,015 22 payments
  5. IMFINZI $1,232 2 payments
  6. LigaSure Vessel Sealing $817 2 payments
  7. Endo GIA $349 5 payments
  8. ALIYA SYSTEM $330 3 payments
  9. ENDO GIA ULTRA $322 7 payments
  10. AtriCure cryoICE cryoSPHERE Cryoablation System $189 1 payment
  11. Other $634 13 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Medtronic, Inc. $17,625 1 payment
  2. TransMedics, Inc. $804 4 payments

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

21

Median for Thoracic Surgery: 42

Drug cost

$291

Median for Thoracic Surgery: $318

Branded share of claims

0%

Median for Thoracic Surgery: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 21 $291

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 910 Part D prescribers listed as Thoracic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 33 billing codes

Paid by Medicare

$78,180

Medicare's payments for the services billed

Medicare patients

116

Average age 73

Services billed

234

57 women, 59 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 66%
Cancer 59%
Arthritis 43%
COPD 38%
Ischemic heart disease 37%
Chronic kidney disease 26%
Diabetes 24%
Atrial fibrillation 24%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

230 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Thoracic Surgery (Cardiothoracic Vascular Surgery) in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record